Takeda

Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Takeda
gene editing
Japan
AnGes
EmendoBio
Flag link:
ASH: Takeda pads case for new leukemia use with 5-year survival data
ASH: Takeda pads case for new leukemia use with 5-year survival data
Fierce Pharma
Takeda
ASH2020
CML
Iclusig
Flag link:
BioCryst takes on Takeda, CSL with FDA approval for Orladeyo, the first pill to prevent HAE attacks
BioCryst takes on Takeda, CSL with FDA approval for Orladeyo, the first pill to prevent HAE attacks
Fierce Pharma
Biocryst
Orladeyo
HAE
FDA
Takeda
CSL Behring
Flag link:
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Fierce Biotech
Takeda
TAK-620
clinical trials
CMV
Flag link:
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Pharmaceutical Business Review
COVID-19
pandemic
clinical trials
Takeda
Amgen
UCB
COVID R&D Alliance
Flag link:
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
Endpoints
Pharvaris
HAE
Takeda
CSL
Flag link:
Takeda to partner on patient-centric data with Seqster
Takeda to partner on patient-centric data with Seqster
Pharmaforum
Takeda
Seqester
patient data
Flag link:
Takeda Joins Forces with Accenture, AWS to Transform to Cloud-Based Company
Takeda Joins Forces with Accenture, AWS to Transform to Cloud-Based Company
BioSpace
Takeda
Accenture
Amazon Web Services
cloud platforms
Flag link:
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
BioPharma Dive
clinical trials
plasma
COVID-19
Takeda
CSL
Flag link:
Takeda drops $300M cash to kick off $1B RNAi alliance with Arrowhead, shooting for first-in-class rare disease drug
Takeda drops $300M cash to kick off $1B RNAi alliance with Arrowhead, shooting for first-in-class rare disease drug
Endpoints
Takeda
RNAi
Arrowhead Pharmaceuticals
Rare Diseases
Flag link:
Fourth-quarter events to watch for big pharma
Fourth-quarter events to watch for big pharma
EP Vantage
COVID-19
clinical trials
AstraZeneca
Gilead Sciences
Takeda
GSK
Roche
Alzheimer's disease
Bristol-Myers Squibb
Pfizer
Eli Lilly
Flag link:
Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub
Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub
Endpoints
Takeda
Boston
cell therapy
drug manufacturing
Flag link:
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
Pharmafile
Takeda
Cheplapharm
M&A
Flag link:
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Motley Fool
Moderna Therapeutics
Japan
Takeda
vaccines
COVID-19
Flag link:
Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?
Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?
Endpoints
Ovid Therapeutics
clinical trials
Takeda
Dravet syndrome
Lennox-Gastaut Syndrome
GW Pharma
Flag link:
Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH
Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH
Endpoints
Takeda
NASH
Engitix
drug development
Flag link:
Takeda to sell Japan consumer health unit to Blackstone for $2B-plus: reports
Takeda to sell Japan consumer health unit to Blackstone for $2B-plus: reports
Fierce Pharma
Takeda
Blackstone Group
M&A
consumer health
Flag link:
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
Fierce Pharma
Takeda
Japan
early retirement
Shire
M&A
Flag link:
Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan
Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan
Motley Fool
Novavax
Japan
vaccines
Takeda
COVID-19
NVX-CoV2373
Flag link:
Takeda hustles to prevent cancer drug shortage after FDA warning letter
Takeda hustles to prevent cancer drug shortage after FDA warning letter
Fierce Pharma
Takeda
FDA
leuprorelin
Hikari
Flag link:

Pages